Nutex Health, Inc. (NUTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 216.49M | 151.68M | 267.8M | 243.99M | 211.79M | 257.62M | 78.79M | 76.08M | 67.45M | 69.67M | 62.72M | 58.92M |
| Revenue Growth % | 2.22% | -41.12% | 239.87% | 220.69% | 213.98% | 269.77% | 25.62% | 29.12% | 19.75% | 29.68% | 120.89% | 1.51% |
| Cost of Goods Sold | 124.75M | 105.54M | 112.92M | 119.06M | 93.45M | 115.99M | 56.88M | 53.52M | 57.3M | 56.46M | 50.91M | 49.28M |
| COGS % of Revenue | 57.63% | 69.58% | 42.17% | 48.8% | 44.12% | 45.02% | 72.19% | 70.35% | 84.94% | 81.03% | 81.17% | 83.63% |
| Gross Profit | 91.73M | 46.14M | 154.88M | 124.92M | 118.34M | 141.63M | 21.92M | 22.56M | 10.16M | 13.21M | 11.81M | 9.65M |
| Gross Margin % | 42.37% | 30.42% | 57.83% | 51.2% | 55.88% | 54.98% | 27.82% | 29.65% | 15.06% | 18.97% | 18.83% | 16.37% |
| Gross Profit Growth % | -22.48% | -67.42% | 606.68% | 453.71% | 1065.07% | 971.84% | 85.54% | 133.87% | 109.52% | 2391.55% | 149.81% | 45.33% |
| Operating Expenses | 14.38M | 15.22M | 24.51M | 91.25M | 46.13M | 27.42M | 12.25M | 17.26M | 8.71M | 39.36M | 12.63M | 10.01M |
| OpEx % of Revenue | 6.64% | 10.03% | 9.15% | 37.4% | 21.78% | 10.64% | 15.55% | 22.69% | 12.91% | 56.49% | 20.14% | 16.99% |
| Selling, General & Admin | 14.38M | 17.82M | 11.3M | 12.5M | 10.04M | 27.43M | 11.83M | 10.59M | 8.71M | 9.14M | 7.84M | 10.01M |
| SG&A % of Revenue | 6.64% | 11.75% | 4.22% | 5.12% | 4.74% | 10.65% | 15.01% | 13.92% | 12.91% | 13.11% | 12.51% | 16.99% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 1000K | 1000K | 1000K | -11.64K | 425.22K | 1000K | 0 | 1000K | 1000K | 0 |
| Operating Income | 81.27M | 30.92M | 130.37M | 33.68M | 72.21M | 114.21M | 9.66M | 5.3M | 1.45M | -26.14M | -821.23K | -362.54K |
| Operating Margin % | 37.54% | 20.38% | 48.68% | 13.8% | 34.09% | 44.33% | 12.26% | 6.96% | 2.15% | -37.53% | -1.31% | -0.62% |
| Operating Income Growth % | 12.54% | -72.93% | 1249.17% | 535.57% | 4881.3% | 536.83% | 1276.62% | 1561.65% | 132.61% | -674.28% | 99.81% | 73.7% |
| EBITDA | 86.76M | 36.1M | 135.37M | 38.93M | 77.3M | 119.49M | 14.64M | 9.83M | 5.64M | -21.46M | 1.07M | 3.81M |
| EBITDA Margin % | 40.08% | 23.8% | 50.55% | 15.95% | 36.5% | 46.38% | 18.57% | 12.92% | 8.36% | -30.81% | 1.7% | 6.47% |
| EBITDA Growth % | 12.23% | -69.78% | 824.96% | 295.93% | 1271.61% | 656.75% | 1272.28% | 157.77% | 1348.68% | -374.3% | 100.25% | 117.46% |
| D&A (Non-Cash Add-back) | 5.49M | 5.19M | 5M | 5.25M | 5.09M | 5.28M | 4.97M | 4.53M | 4.19M | 4.68M | 1.89M | 4.18M |
| EBIT | 0 | 30.92M | 129.39M | 29.41M | 68.88M | 113.63M | 2.8M | 8.96M | 4.29M | -26.47M | -777.76K | -239.01K |
| Net Interest Income | 0 | -4.98M | -5.45M | -5.68M | -6.12M | -5.05M | -5.38M | -5.05M | -4.44M | -4.24M | -4.1M | -4.84M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.68M | 4.98M | 5.45M | 5.68M | 6.12M | 5.05M | 5.38M | 5.05M | 4.44M | 4.24M | 4.1M | 4.84M |
| Other Income/Expense | -4.71M | -5.02M | -6.43M | -9.95M | -9.45M | -5.63M | -12.24M | -1.39M | -1.6M | -4.57M | -4.04M | -4.72M |
| Pretax Income | 76.56M | 25.89M | 123.94M | 23.73M | 62.76M | 108.58M | -2.58M | 3.9M | -152.82K | -30.71M | -4.87M | -5.08M |
| Pretax Margin % | 35.37% | 17.07% | 46.28% | 9.73% | 29.64% | 42.15% | -3.27% | 5.13% | -0.23% | -44.08% | -7.76% | -8.62% |
| Income Tax | 13.8M | 9.29M | 27.14M | 7.59M | 18.54M | 8.61M | 4.58M | 893.89K | 389.67K | -3M | -342.26K | -815.61K |
| Effective Tax Rate % | 18.02% | 35.86% | 21.9% | 31.97% | 29.54% | 7.93% | -177.66% | 22.9% | -254.98% | 9.76% | 7.03% | 16.05% |
| Net Income | 46.81M | 11.83M | 55.44M | -17.7M | 14.63M | 61.7M | -8.79M | -364.05K | -364.07K | -31.62M | -5.54M | -3.48M |
| Net Margin % | 21.62% | 7.8% | 20.7% | -7.25% | 6.91% | 23.95% | -11.15% | -0.48% | -0.54% | -45.38% | -8.84% | -5.9% |
| Net Income Growth % | 219.85% | -80.82% | 730.78% | -4761.17% | 4119.5% | 295.13% | -58.57% | 89.54% | 92.93% | -615.23% | 98.66% | 81.96% |
| Net Income (Continuing) | 46.81M | 16.61M | 96.8M | 16.14M | 44.22M | 99.97M | -7.17M | 3.01M | -542.49K | -27.71M | -4.52M | -4.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 95.76M | 93.99M | 120.87M | 101.63M | 77.77M | 55.55M | 19.34M | 19.29M | 16.99M | 17.65M | 14.98M | 15.61M |
| EPS (Diluted) | 6.52 | 1.62 | 7.76 | -3.02 | 2.56 | 11.12 | -1.72 | -0.07 | -0.08 | -7.50 | -1.25 | -0.79 |
| EPS Growth % | 154.69% | -85.43% | 551.16% | -4025.68% | 3332.32% | 248.27% | -37.6% | 90.73% | 92.86% | -245.62% | 98.75% | 85.5% |
| EPS (Basic) | 6.98 | 1.68 | 8.27 | -3.21 | 2.65 | 11.83 | -1.72 | -0.07 | -0.08 | -7.86 | -1.25 | -0.98 |
| Diluted Shares Outstanding | 7.18M | 7.18M | 7.18M | 5.85M | 5.85M | 5.1M | 5.1M | 4.97M | 4.6M | 4.22M | 4.43M | 4.38M |
| Basic Shares Outstanding | 6.7M | 6.7M | 6.7M | 5.52M | 5.52M | 5.1M | 5.1M | 4.97M | 4.5M | 4.02M | 4.43M | 3.56M |
| Dividend Payout Ratio | - | - | 42.21% | - | 50.32% | 4.5% | - | - | - | - | - | - |